Study summary

The main objective of the study is to evaluate whether the extended duration fidaxomicin therapy is superior to the standard vancomycin therapy in sustained clinical cure of CDI at 30 days after end of treatment (Day 40 or Day 55).

Additional Study Details

Phase
4
Product
N/A
Product
Fidaxomicin
Vancomycin
Type
Interventional
Masking
None (Open Label)
Enrollment number
364
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A Phase IIIB/IV study to compare the efficacy of vancomycin therapy to extended duration of fidaxomicin therapy in the clinical cure of clostridium difficile infection (CDI) in an older population? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Withdrawn
    Site PL48006
    Bydgoszcz, Poland, 80-094
    Completed
    Site DE49008
    Marburg, Germany, 35043
    Completed
    Site GR30009
    Athens, Greece, 12461
    Completed
    Site FI35801
    Helsinki, Finland, 00029
    Completed
    Site PT35106
    Cotter, Portugal, 4835-044
    Completed
    Site HU36008
    Orosháza, Hungary, H-5900
    Completed
    Site HU36007
    Pecs, Hungary, H-7624
    Completed
    Site IT39004
    Milano, Italy, 20122
    Completed
    Site HR38506
    Osijek, Croatia, 31000
    Completed
    Site DE49012
    Hamburg, Germany, 25599
    Completed
    Site DK45004
    Nykøbing Falster, Denmark, 4800
    Completed
    Site RO40003
    Cluj-Napoca, Romania, 400348
    Completed
    Site GB44003
    Sutton in Ashfield, Nottinghamshire, United Kingdom, NG17 4JL
    Completed
    Site FR33008
    Clermont- Ferrand Cedex 1, France, 63003
    Completed
    Site GR30006
    Larisa, Greece, 41221
    Completed
    Site HU36006
    Gyula, Hungary, H-5700
    Completed
    Site RO40001
    Bucharest, Romania, 21105
    Withdrawn
    Site DE49017
    München, Germany, 80336
    Completed
    Site HU36005
    Mosonmagyarovar, Hungary, H-9200
    Completed
    Site HU36009
    Budapest, Hungary, 1088
    Completed
    Site CZ42001
    Praha 8 - Libeň, Czech Republic, 18081
    Completed
    Site HU36010
    Budapest, Hungary, 1082
    Completed
    Site DK45001
    Herlev, Denmark, 2730
    Completed
    Site GR30008
    Athens, Greece, 115 25
    Withdrawn
    Site PL48010
    Lodz, Poland, 90-153
    Completed
    Site BE32008
    Liege, Belgium, 4000
    Withdrawn
    Site DK45003
    Aarhus N, Denmark, 8200
    Completed
    Site DE49001
    Koeln, Germany, 50937
    Completed
    Site IT39009
    Firenze, Italy, 50134
    Completed
    Site BE32005
    Brussels, Belgium, B-1020
    Completed
    Site PL48002
    Warsaw, Poland, 02-781
    Completed
    Site GB44010
    London, United Kingdom, E1 1BB
    Completed
    Site PL48008
    Warsaw, Poland, 02-507
    Completed
    Site TR90001
    Antalya, Turkey, 07059
    Completed
    Site BE32007
    Aalst, Belgium, 9300
    Completed
    Site FR33004
    Nimes, France, 30000
    Completed
    Site BE32006
    Brugge, Belgium, B-8000
    Completed
    Site GB44005
    Cardiff, United Kingdom, CF14 4XW
    Completed
    Site FR33006
    Lille Cedex, France, 59037
    Withdrawn
    Site DE49009
    Jena, Germany, 07747
    Completed
    Site FR33009
    Saint-Priest en Jarez, France, 42270
    Completed
    Site RU70003
    Moscow, Russian Federation, 123423
    Withdrawn
    Site GB44011
    Whythenshawe, Manchester, United Kingdom, M23 9LT
    Completed
    Site IT39001
    Pisa, Italy, 56124
    Completed
    Site DK45005
    Hillerod, Denmark, 3400
    Completed
    Site FR33005
    Nantes, France, 44000
    Completed
    Site SI38605
    Ljubljana, Slovenia, 1000
    Completed
    Site FR33002
    Rennes, France, 35037
    Completed
    Site GB44009
    Truro, United Kingdom, TR1 3LJ
    Completed
    Site ES34005
    Madrid, Madrid, Spain, 28040
    Completed
    Site SE46002
    Göteborg, Sweden, 41685
    Completed
    Site PL48012
    Lodz, PL, Poland, 91-347
    Completed
    Site IT39003
    Monza, Italy, 20900
    Completed
    Site PT35101
    Almada, Portugal, 2800-525
    Completed
    Site HR38501
    Zagreb, Croatia, 10000
    Withdrawn
    Site DE49007
    Bonn, Germany, 53127
    Completed
    Site DE49016
    Lübeck, Germany, 23538
    Completed
    Site TR90007
    Ankara, Turkey, 06100
    Completed
    Site GR30004
    Athens, Greece, 11527
    Completed
    Site AT43003
    Linz, Austria, 4010
    Withdrawn
    Site RU70002
    Saint-Petersburg, Russian Federation, 197341
    Completed
    Site CH41002
    St. Gallen, Switzerland, 9007
    Completed
    Site GR30002
    Herakleion, Crete, Greece, 70013
    Completed
    Site ES34003
    Barakaldo, Vizcaya, Spain, 48903
    Completed
    Site IT39005
    Genova, Italy, 16132
    Completed
    Site PL48003
    Zgierz, Poland, 95-100
    Withdrawn
    Site RU70005
    Smolensk, Russian Federation, 214018
    Completed
    Site IT39007
    Napoli, Italy, 80131
    Withdrawn
    Site GB44012
    Harrogate, United Kingdom, HG2 7SX
    Completed
    Site HU36004
    Bekescsaba, Hungary, H-5600
    Completed
    Site RO40002
    Lasi, Romania, 700116
    Completed
    Site ES34006
    Valencia, Spain, 46026
    Completed
    Site AT43002
    Graz, Austria, 8020
    Completed
    Site IT39010
    Torino, Italy, 10154
    Completed
    Site GB44006
    Bristol, UK, United Kingdom, BS2 8HW
    Completed
    Site BE32001
    Brussels, Belgium, 1000
    Completed
    Site PT35107
    Vila Real, Portugal, 5000-508
    Completed
    Site IE35302
    Dublin, Ireland, 8
    Withdrawn
    Site NO47001
    Fredrikstad, Norway, 1603
    Completed
    Site TR90005
    Istanbul, Turkey, 34662
    Completed
    Site ES34004
    Barcelona, Spain, 08035
    Completed
    Site TR90003
    Adana, Turkey, 01330
    Completed
    Site DE49011
    Köln, Germany, 51067
    Completed
    Site GR30005
    Athens, Greece, 10675
    Withdrawn
    Site RU70004
    Samara, Russian Federation, 443079
    Completed
    Site GR30001
    Athens, Greece, 11527
    Completed
    Site HR38505
    Zadar, Croatia, 23 000
    Completed
    Site PT35104
    Vila Nova de Gaia, Portugal, 4434-502
    Completed
    Site HU36001
    Debrecen, Hungary, H-4043
    Withdrawn
    Site IT39008
    Palermo, Italy, 90127
    Completed
    Site CZ42005
    Kyjov, Czech Republic, 69733
    Completed
    Site PL48004
    Gdynia, Poland, 81-348
    Completed
    Site AT43001
    Salzburg, Austria, 5020
    Completed
    Site FR33007
    Paris, France, 75012
    Completed
    Site PL48011
    Szczecin, Poland, 71-899
    Completed
    Site GR30010
    Thessaloniki, Greece, 546 36
    Completed
    Site CZ42004
    Opava, Czech Republic, 74601
    Completed
    Site CH41001
    Lugano, Ticino, Switzerland, CH-6903
    Completed
    Site SE46005
    Uppsala, Sweden, 75185
    Completed
    Site CZ42002
    Brno-Bohunice, Czech Republic, 62500
    Completed
    Site SI38603
    Murska Sobota, Slovenia, 9000
    Completed
    Site FI35802
    Turku, Finland, 20521
    Completed
    Site SE46001
    Lund, Sweden, 22185
    Withdrawn
    Site GB44004
    Great Yarmouth, United Kingdom, NR31 6LA
    Completed
    Site SE46004
    Jönköping, Sweden, 55185
    Completed
    Site IT39002
    Padova, Italy, 35128
    Completed
    Site DE49006
    Leipzig, Germany, 04103
    Completed
    Site IE35304
    Limerick, Ireland, V94 F858
    Completed
    Site CZ42003
    Praha 5, Czech Republic, 15006
    Completed
    Site FR33003
    Bordeaux, France, 33000
    Completed
    Site TR90006
    Eskisehir, Turkey, 26480
    Withdrawn
    Site SE46006
    Östersund, Sweden, 83183
    Completed
    Site TR90002
    Ankara, Turkey, 06100
    Completed
    Site TR90004
    Istanbul, Turkey, 34890
    Completed
    Site CH41004
    Zürich, Switzerland, 8006
    Withdrawn
    Site HR38502
    Zagreb, Croatia, 10000
    Completed
    Site SI38602
    Maribor, Slovenia, 2000
    Completed
    Site GB44008
    Blackpool, United Kingdom, FY3 8NR
    Completed
    Site RU70001
    Moscow, Russian Federation, 115478
    Completed
    Site PT35102
    Amadora, Portugal, 2720-276
    Completed
    Site SI38601
    Ljubljana, Slovenia, 1000
    Completed
    Site FR33001
    Paris, France, 75010
    Completed
    Site IT39006
    Roma, Italy, 00168
    Completed
    Site GR30007
    Athens, Greece, 14561
    Completed
    Site HR38503
    Rijeka, Croatia, 51000

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?